Page last updated: 2024-11-13

xlr-11

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

XLR-11: synthetic cannabinoid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID57501498
SCHEMBL ID16085972
MeSH IDM0589784

Synonyms (31)

Synonym
5-fluoro ur-144
xlr 11
5-f-ur-144
xlr11
(1-(5-fluoropentyl)indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone
dea no. 7011
l2m8b977ze ,
unii-l2m8b977ze
xlr-11
5'-fluoro-ur-144
hsdb 8372
1-(5-fluoropentyl)-1h-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
AKOS016012346
1364933-54-9
(1-(5-fluoropentyl)-1h-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
SCHEMBL16085972
PXLDPUUMIHVLEC-UHFFFAOYSA-N
(1-(5-fluoro-pentyl)-1h-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
5-fluoro-ur-144
methanone, (1-(5-fluoropentyl)-1h-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-
5f-ur-144
j3.316.072k ,
DTXSID00159825
[1-(5-fluoropentyl)-1h-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
(1-(5-fluoropentyl)-1h-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone
Q8042267
[1-(5-fluoropentyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone
methanone, [1-(5-fluoropentyl)-1h-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-
xlr-11, 1mg/ml in methanol
xlr-11; (1-(5-fluoropentyl)indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone; 5-fluoro-ur-144
xlr-11, 0.1mg/ml in methanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's24 (82.76)24.3611
2020's5 (17.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.33 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies4 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other25 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]